Last reviewed · How we verify
Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions
Approved treatments
- Investigational COVID-19 Vaccine · BioNTech
- BNT162b2 (Omi KP.2) · Pfizer Inc.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions treatment landscape brief
- Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions treatment updates RSS
Frequently asked questions about Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions
What drugs treat Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions?
Tracked treatments include Investigational COVID-19 Vaccine, BNT162b2 (Omi KP.2).
What is the treatment for Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions?
Standard treatment for Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions includes Investigational COVID-19 Vaccine, BNT162b2 (Omi KP.2). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions patent cliff · Prevention of COVID-19 in individuals 12 years of age and older with certain health conditions CI report
- Treatment: Investigational COVID-19 Vaccine · BioNTech
- Treatment: BNT162b2 (Omi KP.2) · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing